SCHEMBL6596289

SCHEMBL6596289

COc1cc2c(cc1OC)N(C(=O)OCc1ccccc1)C(C)CC2=NCc1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ HTR2C P28335 1/20 0.42
▸ PDE1C Q14123 1/20 0.42
▸ PTGDR2 Q9Y5Y4 4/20 0.41
▸ MCL1 Q07820 1/20 0.40
▸ CACNA1G O43497 1/20 0.40
▸ CACNA1H O95180 1/20 0.40
▸ CACNA1I Q9P0X4 1/20 0.40
▸ MEN1 O00255 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.37
▸ PDE4B Q07343 1/20 0.37
▸ TP53 P04637 1/20 0.37
▸ CA1 P00915 1/20 0.37
▸ CA2 P00918 1/20 0.37
▸ ACHE P22303 1/20 0.37
▸ ADRA1D P25100 2/20 0.36
▸ ADRA1A P35348 2/20 0.36
▸ ADRA1B P35368 2/20 0.36
▸ TSHR P16473 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6596287 1.00 HTR2C (0.42) HTR2CPDE1CPTGDR2MCL1CACNA1G
SCHEMBL5405323 0.86 PTGDR2 (0.48) HTR2CPTGDR2CACNA1GCACNA1HCACNA1I
SCHEMBL5405326 0.86 PTGDR2 (0.48) HTR2CPTGDR2CACNA1GCACNA1HCACNA1I
SCHEMBL6596806 0.85 PDE1C (0.47) HTR2CPDE1CPTGDR2MCL1CACNA1G
SCHEMBL6590556 0.82 NPC1 (0.43) HTR2CMEN1KMT2A
SCHEMBL6590549 0.82 NPC1 (0.43) HTR2CMEN1KMT2A
SCHEMBL6589368 0.78 CETP (0.43) HTR2CPTGDR2KMT2A
SCHEMBL6592808 0.77 AGTR2 (0.44) HTR2CMCL1MEN1KMT2AALDH1A1
SCHEMBL6594251 0.77 NPC1 (0.43) PDE1CMEN1KMT2AALDH1A1PDE4B
SCHEMBL5777221 0.76 ALDH1A1 (0.41) MCL1KMT2AALDH1A1CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0987251-B1 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines as CETP inhibitors PFIZER PROD INC (US) 2004-05-19 — — EP disclosed
US-6362198-B1 ANTICHOLESTEROL, ANTILIPEMIC AGENT PFIZER INC. 2002-03-26 — — US disclosed
US-6140342-A CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITOR; USED TO ELEVATE CERTAIN PLASMA LIPID LEVELS, INCLUDING HIGH DENSITY LIPOPROTEIN-CHOLESTEROL AND TO LOWER CERTAIN OTHER PLASMA LIPID LEVELS, SUCH AS LDL-CHOLESTEROL AND TRIGLYCERIDES PFIZER INC. (US) 2000-10-31 — — US disclosed
EP-0987251-A1 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines as CETP inhibitors Pfizer Products Inc. (US) 2000-03-22 — — EP disclosed
Send feedback